Curcumin, a polyphenolic antioxidant, attenuates chronic fatigue syndrome in murine water immersion stress model

Immunobiology

Volumn 214, Issue 1, 2009, Pages 33-39

  Gupta, Amit ^a   Vij, Garima ^a   Sharma, Sameer ^a   Tirkey, Naveen ^a   Rishi, Praveen ^b   Chopra, Kanwaljit ^a  

^a PANJAB UNIVERSITY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Chronic fatigue syndrome; Curcumin; Immunogen; Oxidative stress; Tumor necrosis factor alpha (TNF )

Indexed keywords

ANTIGEN; CURCUMIN; GLUTATHIONE; LIPOPOLYSACCHARIDE; NITRITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BRUCELLA ABORTUS; CHRONIC FATIGUE SYNDROME; CHRONIC STRESS; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; HYPERALGESIA; IMMOBILIZATION; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; WATER IMMERSION;

ANIMALS; ANTIGENS, BACTERIAL; ANTIOXIDANTS; BRUCELLA ABORTUS; CURCUMA; CURCUMIN; DISEASE MODELS, ANIMAL; FATIGUE SYNDROME, CHRONIC; HUMANS; HYPERALGESIA; IMMERSION; IMMOBILITY RESPONSE, TONIC; IMMUNIZATION; LIPOPOLYSACCHARIDES; MICE; OXIDATIVE STRESS; STRESS, PHYSIOLOGICAL; TOUCH; TUMOR NECROSIS FACTOR-ALPHA; WATER;

EID: 58149520292     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2008.04.003     Document Type: Article

References (45)

1. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12 (1994) 141-179
2. Chan M.M. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem. Pharmacol. 49 (1995) 1551-1556
3. Chao C.C., DeLaHunt M., He S., and Perterson P.K. Immunologically mediated fatigue: a murine model. Clin. Immunol. Immunopathol. 64 (1992) 161-165
4. Cleare A.J. The neuroendocrinology of chronic fatigue syndrome. Endocr. Rev. 24 (2003) 236-252
5. Das K., and Das C. Curcumin (diferuloylmethane) a singlet oxygen quencher. Biochem. Biophys. Res. 295 (2002) 62-68
6. Elenkov I.J., Wilder R.L., Chrousos G.P., and Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52 (2000) 595-638
7. Ellman G.L. Tissue sulfhydryl group. Arch. Biochem. Biophys. 82 (1959) 70-77
8. Ferreira L.F., and Reid M.B. Muscle-derived ROS and thiol regulation in muscle fatigue. J. Appl. Physiol. 104 (2008) 853-860
9. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., and Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann. Intern. Med. 121 (1994) 953-959
10. Gaab J., Rohleder N., Heitz V., Engert V., Schad T., Schürmeyer T.H., and Ehlert U. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome. Psychoneuroendocrinology 30 (2005) 188-198
11. Holmes G.P., Kaplan J.E., Grantz N.M., Komaroff A.L., and Strass S.E. Chronic fatigue syndrome: a working case definition. Ann. Intern. Med. 108 (1988) 387-389
12. Jain N.K., Kulkarni S.K., and Singh A. Lipopolysaccharide-mediated immobility in mice: reversal by cyclooxygenase enzyme inhibitors. Methods Findings Exp. Clin. Pharmacol. 23 (2001) 441-444
13. Johansson S., Bohman S., Radesater A.C., Oberg C., and Luthman J. Salmonella lipopolysaccharide (LPS) mediated neurodegeneration in hippocampal slice cultures. Neurotox. Res. 8 (2005) 207-220
14. Kannan S.A., Saade N.E., Haddad J.J., Abdelnoor A.M., Atweh S.F., Jabbur S.J., and Garabelian B.S. Endotoxin induced local inflammation and hyperalgesia in rats mince, a new model for inflammatory pain. Pharmacology 66 (2003) 373-379
15. Kaur S., Anurag A., Tirkey N., and Chopra K. Reversal of LPS-induced central and peripheral hyperalgesia by green tea extract. Phytother. Res. 19 (2005) 39-43
16. Kawaguchi K., Omari K., and Okita K. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrohis induced by a choline deficient l-amino acid-deficient diet. Biochem. Biophys. Commun. 315 (2004) 187-195
17. Klimas N.G., and Koneru A.O. Chronic fatigue syndrome: inflammation, immune function and neuroendocrine interactions. Curr. Rheumatol. Rep. 9 (2007) 482-487
18. Kuhad A., Pilkhwal S., Sharma S., Tirkey N., and Chopra K. Effect of curcumin on inflammation and oxidative stress in cisplatin-induced experimental nephrotoxicity. J. Agric. Food Chem. 55 (2007) 10150-10155
19. Lerner A.M., Beqaj S.H., Deeter R.G., and Fitzgerald J.T. IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome. In Vivo 18 (2004) 101-106
20. Lloyd A.R., Wakefield D., Boughton C.R., and Dwyer J.M. Immunologic abnormalities in the chronic fatigue syndrome. Med. J. Aust. 151 (1989) 122-124
21. Logan A.C., and Wong C. Chronic fatigue syndrome: oxidative stress and dietary modifications. Altern. Med. Rev. 6 (2001) 450-459
22. MacDonald K.L., Osterholm M.T., LeDell K.H., White K.E., Schenck C.H., Chao C.C., Persing D.H., Johnson R.C., Barker J.M., and Peterson P.K. A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome. Am. J. Med. 100 (1996) 548-554
23. Maes M., Mihaylova I., and Bosmans E. Not in the mind of neurasthenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta. Neuroendocrinol. Lett. 28 (2007) 456-462
24. McKenna M.J., Medved I., Goodman C.A., Brown M.J., Bjorksten A.R., Murphy K.T., Petersen A.C., Sostaric S., and Gong X. N-acetylcysteine attenuates the decline in muscle Na+,K+-pump activity and delays fatigue during prolonged exercise in humans. J. Physiol. 576 (2006) 279-288
25. Morganti-Kossmann M.C., Rancan M., Stahel P.F., and Kossmann T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr. Opin. Crit. Care 8 (2002) 101-105
26. O'Flaherty J.T. Lipid mediators of inflammation and allergy. Lab. Invest. 47 (1982) 314-329
27. Ottenweller J.E., Natelson B.H., Gause W.C., Carroll K.K., Beldowicz D., Zhou X.D., and Lamanca J.J. Mouse running activity is lowered by Brucella abortus treatment: a potential model to study chronic fatigue. Physiol. Behav. 63 (1998) 795-801
28. Pall M.L. Elevated peroxynitrite as the cause of chronic fatigue syndrome. Med. Hypoth. 54 (2000) 115-125
29. Pall M.L. Elevated peroxynitrite as the cause of chronic fatigue syndrome: other inducers and mechanisms of symptom generation. J. Chronic Fatigue Syndr. 7 (2000) 45-58
30. Punithavathi D., Venkatesan N., and Babu M. Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats. Br. J. Pharmacol. 139 (2003) 1342-1350
31. Quan N., and Herkenham M. Connecting cytokines and brain: a review of current issues. Histol. Histopathol. 17 (2002) 273-288
32. Quan N., Stern E.L., Whiteside M.B., and Herkentram M. Induction of proinflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J. Neuroimmunol. 93 (1999) 72-80
33. Sakaguchi S., and Furusawa S. Oxidative stress and septic shock: metabolic aspects of oxygen-derived free radicals generated in the liver during endotoxemia. FEMS Immunol. Med. Microbiol. 47 (2006) 167-177
34. Sharma S., Chopra K., and Kulkarni S.K. Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin. Exp. Pharmacol. Physiol. 33 (2006) 940-945
35. Sharma S., Chopra K., and Kulkarni S.K. Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytother. Res. 21 (2007) 278-283
36. Singh A., Garg V., Gupta S., and Kulkarni S.K. Role of antioxidants in chronic fatigue syndrome in mice. Ind. J. Exp. Biol. 40 (2002) 1240-1244
37. Sugino K., Dohi K., Yamada K., and Kawasaki T. The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effects of antioxidants. Surgery 101 (1987) 746-750
38. Sumanont Y., Murakami Y., Vajrajgupta O., and Watanable H. Evaluation of nitric oxide radical scavenging activity of manganese complexes of curcumin and its derivatives. Biol. Pharm. Bull. 27 (2004) 170-173
39. Svetic A., Jian Y.C., Lu P., and Finkelman F.D. Brucella abortus induces a novel cytokine gene expression characterized by elevated IL-10 and IFN-γ in CD4+ T cells. Int. Immunol. 5 (1993) 877-883
40. Thiyagarajan M., and Sharma S.S. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci. 74 (2004) 969-985
41. Tirkey N., Kaur G., Vij G., and Chopra K. Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidney. BMC Pharmacol. 5 (2005) 15
42. Vajrajgupta O., Boonchoong P., Watanable H., and Sumanont Y. Manganese complexes of curcumin and its derivatives: evaluation for the radical scavenging ability and renoprotective activity. Free Radic. Biol. Med. 35 (2003) 1632-1644
43. Wang X.Q., Takahashi T., Zhu S.J., Moriya J., Saegusa S., Yamakawa J., Kusaka K., Itoh T., and Kanda T. Effect of Hochu-ekki-to (TJ-41), a Japanese herbal medicine, on daily activity in murine model of chronic fatigue syndrome. Evid. Based Complement. Altern. Med. 1 (2004) 203-206
44. Wills E.D. Mechanism of lipid peroxide formation in animal tissues. Biochem. J. 99 (1996) 667-676
45. Yoshikawa Y., Takano H., Takahashi S., and Ichikawa H. Changes in the tissue antioxidant enzyme activities and lipid peroxides in endotoxin-induced multiple organ failure. Circ. Shock 42 (1994) 511-523